Companies: 10,795·Total market cap: $144.5T
I-Mab

I-Mab

IMABNASDAQHealthcare
$2.88
$-0.02(-0.69%)
Market Cap$542009454
P/E Ratio
52W High$6.79
52W Low$0.595
Overview

I-Mab (IMAB) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

imab · stock forecast · 5 analysts (3M) · FMP · updated Mar 18, 2026

Analyst Rating & Consensus

Based on 5 Wall Street analysts in the past 3 months

SellBuy

Buy

5 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
5
Hold
0
Sell
0
Strong Sell
0
Total: 5 · Buy rate: 100.0%

12-Month Price Target

High

$9.00

Consensus

$7.75

+92.3% upside

Low

$7.00

Median: $7.5 · Last Close: $4.03

The I-Mab (IMAB) analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month IMAB price target is $7.75, representing +92.3% upside from the current price of $4.03.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $8 (92.3%)

Consensus Target

$7.75

92.3% upside

High Target

$9

123.3%

Low Target

$7

73.7%

Current Price

$4.03

as of today

Based on analyst price targets, the IMAB stock price prediction for the next 12 months ranges from $7 to $9. The consensus IMAB price forecast of $7.75 implies 92.3% upside from the current price of $4.03.

Short-Term Price Prediction

Low Activity

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$4.194.04%

1-day model range: $4.12–$4.27. Peak: $4.27 (+4.04%).

Long-Term Stock Price Prediction

⚠️ Long-term projections are hidden until 252 trading days of history (IPO / limited listing). Short-term tab may still show model output.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

🚫

Insufficient Trading Activity — Sentiment Signals Disabled

This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.

RSI (14)50.2
MACDBULLISH

Moving Averages · IMAB · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$4.38SELL
MA 10$4.25SELL
MA 20$4.10SELL
MA 50$4.30SELL
MA 100$4.33SELL
MA 200$0.00NEUTRAL
Current $IMAB · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$4.27SELL
EMA 10$4.24SELL
EMA 20$4.19SELL
EMA 50$4.21SELL
EMA 100$3.90BUY
EMA 200$0.00NEUTRAL
Current $IMAB · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
BTIG2025-10-24
Maintains
BuyBuy
BTIG2025-10-17
Maintains
BuyBuy
BTIG2025-09-10
Maintains
BuyBuy
Needham2025-09-08
Maintains
BuyBuy
HC Wainwright & Co.2025-08-21
Maintains
BuyBuy
Needham2025-08-20
Maintains
BuyBuy
HC Wainwright & Co.2025-07-09
Maintains
BuyBuy
Needham2025-07-09
Maintains
BuyBuy
Needham2025-06-27
Maintains
BuyBuy
Needham2025-04-04
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on I-Mab (IMAB) stock. Of the recent 39 rating actions, 0 were upgrades and 0 were downgrades. 5 analysts currently cover IMAB.

Analyst Recommendation Trends

Buy ratings22
Hold ratings00
Sell ratings00

IMAB analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$5M

↓ 74.6% YoY

Revenue Next Year

$10M

↑ 96.8% YoY

EPS This Year

$-2.35

EPS Next Year

$-3.58

↑ 52.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast IMAB EPS of $-2.35 for the current fiscal year, based on estimates from 3 analysts. The IMAB revenue forecast is $5M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The IMAB stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus IMAB price target is $7.75 (+92.3% upside), with an analyst consensus of Buy.

The IMAB short-term stock prediction for tomorrow is $4.19 (+4.04%).

I-Mab trades on NASDAQ under the ticker IMAB. The IMAB stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

IMAB forecast · 8 questions

According to 5 Wall Street analysts, the average 12-month IMAB price target is $7.75, with a high forecast of $9.00 and a low of $7.00. The median price target is shown in the chart above when available. This implies +92.3% potential upside from the current price of $4.03.

IMAB price targetWhat is IMAB price targetIMAB analyst price targetIMAB 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.